SIGN UP NOW: Join Bionj & Health Care Leaders In New Jersey In Protecting Patients & Medical Innovation

New Jersey’s innovative life sciences industry develops groundbreaking treatments and cures that Patients everywhere depend on. Medical innovation also supports a healthy New Jersey economy. But a threat is looming. Patients and innovation itself may be endangered by one-size-fits-all methods to determine drug value and access.

The Institute for Clinical and Economic Review (ICER) is a research group that uses a controversial method to determine the value of drugs that ignores individual Patient preferences.

Because Patients Can’t Wait®, any solution to control health care costs in New Jersey must promote innovation, incorporate the unique needs of Patients, and ensure access to care.

Join an exclusive network of New Jersey policy and health care leaders to protect medical innovation and access to life-changing treatments for New Jerseyans and all Americans. Sign up and we’ll send you email opportunities to take action online and in your community.